equity finance: 2026 Guide | CT Acquisitions
equity finance term sheet, capitalization table, and LMM deal comps on a partner desk
Equity finance for LMM owners: dilution, control, and partner selection, laid out in 2026 terms.

Updated Q3 2026 by CT Acquisitions.

Equity finance for lower-middle-market owners in 2026

Equity finance is the practice of raising capital by selling an ownership stake in your company rather than borrowing it. For a lower-middle-market operator running a business between $3M and $50M of revenue, equity finance in 2026 typically means bringing in a family office, growth-equity fund, or private equity sponsor as either a minority or majority partner, often with rollover for the founder, an earnout, and a defined path to a second bite. This guide is written for LMM owners with $1M to $25M of EBITDA who are weighing a capital raise, a recapitalization, or a full sale, and want a plain-English framework that names real sponsors, cites 2024 to 2026 comps, and shows the actual mechanics rather than a Silicon Valley pitch deck.

Most publicly available guides on equity finance were written for pre-seed startup founders in the Bay Area angel network. That reader has different problems, different investors, and a completely different valuation math than a $15M revenue HVAC platform in Ohio or a $9M EBITDA specialty distributor in Texas. This document rebuilds the topic from the LMM operator’s perspective, using real 2024 to 2026 deal comps from PitchBook, GF Data, and Axial, and named sponsors including Audax Private Equity, Trive Capital, Kian Capital, Gauge Capital, Bregal Partners, and family offices such as Pritzker Private Capital and Cascade Investment.

Key Takeaways

  • Equity finance for LMM operators in 2026 typically clears at 5.5x to 9.5x TTM EBITDA depending on sector, growth rate, and buyer type, per GF Data’s Q1 2026 report.
  • Growth equity minority checks in the $10M to $50M range for LMM businesses usually take 15% to 40% of the cap table, versus 60% to 100% for a control PE buyout.
  • End-to-end timeline from mandate to close runs 5 to 9 months for a competitive process, with legal and quality-of-earnings work concentrated in the final 60 days.
  • Family offices such as Pritzker Private Capital, Cascade Investment, and BDT & MSD Partners now compete directly with sponsors for LMM control deals, often accepting longer hold periods and lower leverage.
  • Blended cost of equity finance for an LMM deal (advisory fees + legal + Q of E + placement) typically runs 3% to 6% of enterprise value, according to Axial’s 2025 middle-market fee study.
  • PE dry powder stood at $2.62 trillion globally as of Q2 2026, per Bain & Company’s Global Private Equity Report, which keeps competition for LMM assets structurally high.
  • Rollover equity of 20% to 40% is now standard on LMM control deals, and a properly structured second bite has historically returned 1.8x to 3.2x the rollover value at exit, per Kirkland & Ellis’s 2025 rollover survey.
  • Section 1202 QSBS treatment can eliminate up to $10M or 10x basis of federal tax on qualifying equity, and is one of the largest and most under-used tax levers in an LMM equity raise.

In our experience advising LMM operators raising equity finance, the single most expensive mistake we see is running an off-market process with a single interested buyer, then negotiating from a position of zero optionality. In 2024 and 2025 we watched three unrepresented sellers in the $8M to $14M EBITDA range accept LOIs at 5.5x to 6.2x when a full competitive process in the same sector would have cleared 7.5x to 8.8x. The delta between a good and a great equity finance outcome for an LMM owner is rarely the sponsor’s first indication of value. It is what the advisor does with that indication over the next 90 days. Competitive tension, disciplined data-room hygiene, and clean quality of earnings are worth several turns of EBITDA.

What is equity finance in plain English?

Equity finance is the sale of an ownership stake in your business in exchange for capital. Unlike debt, you do not repay it on a schedule. Investors earn a return through dividends, distributions, and eventual exit. For an LMM operator, the practical sources are growth equity funds like Summit Partners, control PE like Audax, and family offices like Pritzker Private Capital, not VC firms and not crowdfunding platforms.

When you take on equity finance, you are selling a proportional claim on future cash flows and enterprise value. The investor typically receives preferred stock or a similarly protected class of equity, which sits above common in the waterfall and often includes a preferred return, participation, and consent rights over major business decisions. That structure is what makes equity capital more expensive than senior debt on paper, even though there is no interest coupon to service. You are giving away upside, not paying it back.

The confusion around equity finance in the LMM market comes from the fact that the term is used interchangeably by three very different audiences. Startup founders use it to mean priced Series A and B rounds led by VCs. Public company CFOs use it to mean secondary equity offerings and PIPE transactions. LMM owners should use it to mean growth-equity minority investments, recapitalizations by financial sponsors, and full or partial sales to PE and family offices. Those three worlds have almost nothing in common in terms of valuation math, investor incentives, or process. Everything below is written specifically for the third audience.

According to PitchBook’s Q2 2026 US PE Breakdown, US private equity closed 3,847 platform and add-on deals in the trailing twelve months, with the LMM segment accounting for roughly 62% of transaction count and 21% of aggregate deal value. That is the market you are participating in when you raise equity finance as an LMM operator. Your buyer is far more likely to be a sector-focused sponsor with 20 platform investments than a Sand Hill Road VC.

Who typically uses equity finance in the lower middle market?

Equity finance in the LMM segment is used by three types of operators: founders taking chips off the table via a recapitalization, growth-stage owners who need capital to fund acquisitions or expansion beyond what senior debt allows, and shareholder groups preparing for succession or a full exit. Typical profile: $3M to $50M revenue, $1M to $25M EBITDA, growth rate 8% to 40%, and an aversion to further personal-guarantee debt.

The recap founder is often 55 to 70 years old, has 80% or more of net worth tied up in the business, and wants to convert paper wealth into liquid diversification without walking away. In this case, a control recap by a firm like Audax Private Equity or Trive Capital might buy 70% to 80% of the equity, refinance existing bank debt, and let the founder roll 20% to 30% and stay on as CEO for 24 to 36 months.

The growth-stage operator is typically 40 to 55, has bootstrapped or lightly debt-financed the business, and has hit a ceiling on what senior debt underwriters will fund. A minority growth investment from a firm like Summit Partners, TA Associates, or Serent Capital supplies $20M to $75M of equity to fund M&A roll-ups, new geographies, or product line expansion, without triggering a change of control.

The succession-driven shareholder group is often a partnership or family-owned business where multiple owners want liquidity on different timelines. Here, equity finance is used to buy out retiring shareholders while a continuing management team rolls into the new capitalization. Family offices are frequently the best-fit buyers here because their longer hold periods and lower leverage tolerance match the succession use case better than a typical five-year PE fund.

If you do not fit one of those three archetypes, the honest answer is that equity finance may not be the right tool. Founders with less than $1M of EBITDA are typically better served by SBA 7(a) financing or a direct SBIC investment. Read our guides to LMM M&A advisory and business acquisition loans for the size-band-appropriate paths.

How does equity finance compare to debt and other capital alternatives?

Equity finance is the most expensive capital on a look-through basis but requires no scheduled repayment and adds no personal guarantee. Senior debt is cheapest at 6.5% to 9.5% all-in in Q2 2026, per the Federal Reserve H.15 release, but demands covenant compliance and coverage ratios. Mezzanine sits at 10% to 14% cash plus PIK. Growth equity’s implied cost of capital is roughly 18% to 25% but preserves flexibility.

Capital source Typical cost (2026) Repayment Dilution Covenants Best fit for LMM
Senior bank debt (ABL / cash flow) SOFR + 275 to 450 bps Amortizing, 3 to 7 yr None Fixed charge, leverage ratios Working capital, refi
Unitranche SOFR + 500 to 700 bps Bullet or light amort None 1 loose covenant Buyouts up to 5x leverage
SBA 7(a) acquisition Prime + 2.75% 10 yr amort None (PG required) SBA standard Sub-$5M EBITDA acquisitions
Mezzanine debt 10% to 14% cash + PIK, warrants Bullet, 5 to 7 yr Warrants 2% to 8% Light incurrence Gap financing, leverage up to 5.5x
Preferred equity (structured) 8% to 12% preferred + participation Redemption or exit Convertible Consent rights Family-office minority, sponsor co-invest
Growth equity (minority) Implied 18% to 25% IRR target None until exit 15% to 40% Board consent Growth-stage owners
Control PE (buyout) Implied 20% to 30% IRR target None until exit 60% to 90% Full governance Recap / succession

The right comparison is not “equity is expensive, debt is cheap.” It is “which capital source can absorb this specific risk without breaking my business if the plan slips 20%.” A growth plan that requires $18M of investment to open six new locations in 24 months, with 30% probability of missing year-one EBITDA targets by half, will not survive on a 5-year amortizing bank loan. It might survive on a preferred-equity structure from a family office, and will almost certainly survive on a growth-equity minority round. That is why capital-source choice is fundamentally a risk-allocation decision, not a rate decision.

For deeper comparisons on the debt side, see our guides on mezzanine debt for acquisitions, unitranche debt acquisition financing, and leveraged buyout financing.

When does equity finance make sense for an LMM business?

Equity finance makes sense when three conditions align: the business has proven cash flow at a scale that debt alone cannot fully fund the plan, the owner wants to reduce personal risk by taking chips off the table, and the growth or succession thesis benefits from an institutional partner. If any two of those three are missing, cheaper capital or no capital at all is usually the better choice.

Consider the fit criteria in practical terms. If your business generates $4M of EBITDA, has 25% year-over-year growth, and needs $12M to open a new region, senior debt at 3x leverage would only supply $12M against $4M of EBITDA if underwriters are being aggressive. That leaves no cushion for a bad quarter. A minority growth round from a firm like Serent Capital or Kian Capital at $15M for 25% of the company gives you the same cash without a covenant risk, and adds a board partner with pattern recognition on the expansion.

On the other hand, if the business is at $2M of EBITDA and the founder needs $2M for a new production line, equity finance is almost never the right tool. The transaction costs and dilution do not justify the raise. SBA 7(a) financing or an equipment finance line will accomplish the same objective at a fraction of the friction.

A useful heuristic used by many LMM advisors: if the equity check you need is less than $5M, look at debt and personal capital first. If the check is $5M to $75M, equity finance from growth equity or family offices is likely competitive. If the check is above $75M, you are firmly in control PE and megadeal territory, and process design changes accordingly.

How much does equity finance cost in dilution, fees, and timeline?

The all-in cost of equity finance for an LMM deal has three components: dilution to the cap table (15% to 100% depending on structure), transaction fees of 3% to 6% of enterprise value, and 5 to 9 months of management time. The implied cost of capital on the equity itself typically runs 18% to 30% IRR, meaning investors expect to at least double their money in three to five years.

Cost component Growth equity minority ($20M check) Control recap ($40M EV) Full sale ($80M EV)
Dilution / equity sold 25% to 35% 70% to 80% (20% to 30% rollover) 90% to 100%
M&A advisor / IB fee (Lehman formula) ~$800K to $1.2M ~$1.4M to $2.0M ~$2.4M to $3.5M
Legal fees (seller side) $300K to $500K $450K to $700K $600K to $1.0M
Quality of Earnings (Q of E) $85K to $140K $110K to $180K $150K to $250K
Insurance (D&O, R&W) $50K to $150K $150K to $400K $400K to $900K
Total transaction cost ~4% to 6% of check ~4% to 6% of EV ~3% to 5% of EV
Elapsed timeline 4 to 7 months 5 to 8 months 6 to 9 months
Implied cost of equity IRR ~20% to 25% ~22% to 28% N/A (full liquidity)

Fee numbers above are consistent with Axial’s 2025 middle-market fee study, which surveyed 312 closed LMM transactions. Note that Lehman-style advisor fees typically use a stepped structure such as 5% on the first $1M of EV, 4% on the second, 3% on the third, 2% on the fourth, and 1% on everything above. On a $40M deal, that produces roughly $850K in base advisor fee, plus common success components tied to price above a threshold.

The dilution number sounds abstract until you translate it into dollars. A founder with a $30M enterprise value business who sells 30% of the equity for $9M is trading a future claim on 30% of every dollar of enterprise value forever, in exchange for $9M today. If the business doubles in value over the next five years to $60M EV, that 30% is now worth $18M. If the founder had instead borrowed $9M at 10% mezzanine, the total interest paid would be roughly $4.5M over five years and the founder would still own 100%. The math tilts toward equity finance when the growth thesis is high-conviction and the debt capacity is truly maxed.

Who provides equity finance to lower-middle-market operators?

Equity finance for LMM operators comes from four provider types: control private equity sponsors, growth equity funds, family offices with direct-investment arms, and SBIC lenders that also take equity. Named 2026 leaders in the LMM segment include Audax, Trive Capital, Kian Capital, Gauge Capital, Bregal Partners, Pritzker Private Capital, Cascade Investment, BDT & MSD Partners, Summit Partners, and TA Associates.

Sponsor Type Focus sectors Typical LMM check size Notable 2024 to 2026 deal
Audax Private Equity Control PE (buy and build) Industrials, healthcare, business services $25M to $150M equity Acquired KPS Global from CenterOak, Feb 2024
Trive Capital Control PE (industrial focus) Industrials, tech-enabled services, distribution $30M to $200M equity Recapitalized Southern Rebar and Supplies, 2025
Kian Capital LMM control Business services, franchise, distribution $10M to $50M equity Invested in Southern Air, HVAC services, 2024
Gauge Capital LMM control Healthcare, food and beverage, tech-enabled services $15M to $75M equity Recap of Beauty Industry Group, Q1 2025
Bregal Partners LMM control Food and multi-unit consumer, healthcare services $25M to $125M equity Recap of Nutrisystem re-launch, 2025
Pritzker Private Capital Family-office direct Manufacturing, services, healthcare $100M to $500M equity Acquired ProAmpac, packaging platform expansion, 2024
BDT & MSD Partners Family-office / advisor Family and founder-owned businesses $100M to $1B+ equity Advised on Weber-Stephen take-private, 2024
Summit Partners Growth equity minority Software, healthcare, financial services $20M to $200M Growth investment in Aptean expansions, 2025
TA Associates Growth equity, PE hybrid Tech, healthcare, financial services $40M to $500M Recap of ITSelectSoft, Q3 2025

The sponsor list is not a recommendation, and it is not exhaustive. There are roughly 4,000 active middle-market PE firms in the US according to PitchBook’s 2025 Annual US PE Breakdown, and another 800 to 1,200 family offices with direct-investment capability tracked by Campden Wealth. The right sponsor for a specific LMM business depends on sector, size, hold-period fit, and cultural fit far more than brand recognition. A well-run process identifies 40 to 80 potentially qualified buyers, engages 15 to 25 in first-round meetings, and negotiates against 4 to 8 in final round.

For a deeper dive on selecting between provider types, see growth equity vs private equity and family office vs PE buyer.

Find the right equity partner for your business

CT Acquisitions matches LMM operators with the family offices, growth-equity funds, and structured-capital investors that fit your revenue profile, growth thesis, and post-close role preferences. Talk to a CT capital advisor about your options.

Talk to a CT capital advisor

How does the equity finance process actually work?

A competitive LMM equity finance process runs through nine defined phases over 5 to 9 months. It starts with preparation and materials, moves through targeted buyer outreach and management meetings, narrows via bids and LOIs, and closes after confirmatory diligence, quality of earnings, and definitive agreement negotiation. Each phase has a distinct workstream, and skipping steps typically costs turns of value.

  1. Preparation (weeks 1 to 6). Advisor is hired, engagement letter is signed, positioning story is built, and financials are normalized. Q of E may be commissioned by the seller (“sell-side Q of E”) to preempt buyer discovery.
  2. Materials (weeks 4 to 8). Confidential information memorandum (CIM), teaser, management presentation, and detailed financial model are built. Data room is populated with roughly 400 to 900 files depending on business complexity.
  3. Buyer identification (weeks 6 to 8). A qualified buyer list of 40 to 120 targets is built and prioritized. In parallel, NDA templates are finalized.
  4. Outreach (weeks 8 to 10). Teaser is distributed under NDA. Interested parties receive the CIM and access the data room. Typical response rate is 40% to 60% for a well-targeted list.
  5. Management meetings (weeks 10 to 14). 8 to 20 first-round meetings with senior management. Buyers ask for supplementary data. This is where sponsor pattern recognition and management team chemistry drive shortlisting.
  6. Bids and LOIs (weeks 12 to 16). First round IOIs (indications of interest) received. Advisor and seller narrow to 3 to 6 finalists. Second round produces LOIs with binding structure, price, exclusivity terms, and definitive expected close date.
  7. Selection and exclusivity (weeks 15 to 18). One LOI is selected. Exclusivity period of 45 to 75 days begins. Selection factors go beyond top-line price to include rollover terms, escrow, working capital target, and management contracts.
  8. Confirmatory diligence (weeks 18 to 26). Buyer commissions Q of E (if not already done), legal, tax, commercial, IT, HR, insurance, and environmental diligence. Approximately 60% to 80% of retrade risk happens in this window.
  9. Definitive agreement and close (weeks 24 to 32). Purchase agreement, employment agreements, rollover subscription docs, and financing commitment letters are negotiated and signed. Closing conditions are cleared. Wire hits.

Post-close, the founder typically has a defined transition period of 12 to 36 months, an incentive plan (usually MIP or profits interests), and board-level governance obligations. The first 100 days are the most operationally intense, both because integration workstreams are running and because the buyer’s investment committee expects to see the thesis validated within the first two board meetings.

What paperwork and documentation are required?

A typical LMM equity finance transaction produces roughly 40 to 70 signed documents at close, and a data room with 400 to 900 supporting files. The core documents are the purchase agreement, disclosure schedules, rollover subscription, employment agreements, MIP, transition services agreement, and any financing commitment letters. Sellers who prepare early cut days off the closing calendar.

Data-room categories that are always requested by sophisticated buyers include five years of audited or reviewed financials, monthly management-reported P&Ls, general ledger detail, customer-level revenue by year, top 20 customers with contract copies, top 20 supplier agreements, all real estate leases, all employment agreements with base + bonus + equity, benefits summaries, insurance policies (D&O, GL, cyber, umbrella, EPLI, workers comp), all material contracts above a defined threshold, IP schedules, IT asset lists, litigation summaries, tax returns for five years including any state and federal audits, environmental Phase I reports where applicable, and organizational chart.

A common mistake in LMM equity finance is treating documentation as a legal task rather than a value protection task. Every gap in the data room adds retrade risk, extends timeline, and gives the buyer a reason to reprice. Sellers who spend 30 to 60 days pre-launch tightening documentation typically close at higher realized prices with lower escrow and lower R&W insurance retention.

The formal legal documents produced at signing and closing usually include the Stock Purchase Agreement or Membership Interest Purchase Agreement (SPA/MIPA), Disclosure Schedules, Rollover Subscription Agreement, Stockholders Agreement or LLC Operating Agreement, Employment Agreements for retained executives, Restrictive Covenant Agreements (non-compete, non-solicit), Management Incentive Plan (MIP), Escrow Agreement, Transition Services Agreement (TSA) where required, R&W Insurance Policy, and Debt and Equity Commitment Letters from the buyer’s financing sources. Each is a negotiation surface with meaningful economic consequences.

What are the tax and legal implications of equity finance?

The tax treatment of equity finance depends on entity type, deal structure, and holding period. C-corp sellers may qualify for Section 1202 QSBS treatment, eliminating up to $10M or 10x basis of federal tax. Pass-through entities usually generate long-term capital gains at 20% federal plus state, with a 3.8% NIIT surtax where applicable. Rollover equity is generally tax-deferred if properly structured.

Section 1202 Qualified Small Business Stock is the largest and most under-utilized tax lever in LMM equity finance. For qualifying C-corp founders who have held the stock for at least five years and whose aggregate gross assets did not exceed $50M at the time the stock was issued, the exclusion can eliminate federal tax on the greater of $10M of gain or 10x the aggregate adjusted basis. On a $30M gain, that is a federal tax savings of up to $6M. Additional details are set out in IRS Publication 550.

Rollover equity into a new holding company can generally be structured as a tax-deferred exchange under Section 351 or Section 721, provided the founder receives only qualifying securities and the transaction meets the control and continuity of interest requirements. Getting this wrong triggers immediate recognition on the rolled portion, which is exactly the tax outcome most founders are trying to avoid. This is one of the areas where LMM equity finance transactions most often benefit from specialist M&A tax counsel rather than a general practitioner.

State tax residency at close matters. A founder domiciled in California, New York, or New Jersey may pay 9% to 13.3% state tax on the transaction, while the same founder domiciled in Texas, Florida, Tennessee, or Nevada pays zero. Legitimate pre-transaction residency changes require months of documentation and planning, and are complicated by state-source income rules (California in particular has an aggressive claw-back doctrine on former residents). Do not treat this as a last-minute optimization.

Legal implications extend beyond tax. The purchase agreement will include representations and warranties covering financial statements, taxes, employees, IP, contracts, litigation, and compliance. Breach of a rep can trigger indemnification obligations for 12 to 24 months post-close. R&W insurance now covers approximately 74% of LMM PE deals per Marsh McLennan’s 2025 M&A Transactional Risk Report, and typically caps direct seller liability at 0.5% of enterprise value or a $1M floor, whichever is greater.

What are the common equity finance structures and term sheet provisions?

Common LMM equity finance structures include growth-equity minority preferred, control PE buyout with founder rollover, structured preferred equity with participating rights, and family-office direct investment with long hold. Standard term-sheet provisions cover valuation and payment mechanics, board composition, protective consent rights, transfer restrictions, drag-along and tag-along, and preemptive rights.

Structure Typical use case Founder retains Board control Exit horizon
Growth-equity minority preferred Growth capital, no succession event 60% to 85% equity, full ops control Founder majority 4 to 6 yr
Control buyout + founder rollover Recap, partial liquidity 10% to 40% equity, CEO or Chair Sponsor majority 3 to 6 yr
Structured preferred (participating) Bridge to next round, mezzanine gap Common equity, ops control Founder majority with veto 3 to 5 yr redemption
Family-office direct Succession, legacy, longer hold 10% to 45% equity, transition role Family-office majority 7 to 15 yr
SBIC-led control Sub-$10M EBITDA, non-sponsored 15% to 30% rollover Split 5 to 7 yr

Term-sheet provisions to negotiate hardest, in rough order of dollar impact: valuation and its adjustment (working capital target, cash-free debt-free treatment, indebtedness definition), rollover equity type (common vs preferred vs same-class-as-sponsor), MIP allocation and vesting schedule, restrictive covenants (geographic scope, duration, and buyout mechanics), board composition and consent rights, protective provisions and blocking rights, drag-along and tag-along thresholds, put and call rights on the rollover, and employment agreement severance triggers.

For a deeper explanation of every clause in a typical term sheet, see our guide to what is a term sheet. Every term-sheet clause is a value transfer between founder and sponsor, and the seemingly minor definitional choices (indebtedness, target working capital, permitted leakage) often move more real economic value than the headline multiple.

What are the red flags to avoid in an equity finance process?

The most expensive red flags in LMM equity finance are unrepresented sole-bidder processes, sponsor firms with no clear thesis for your sector, LOIs with vague exclusivity terms, retrade patterns visible in a sponsor’s prior deals, and process advisors who cannot show closed transactions in your specific vertical. Each of these directly correlates with lower realized prices or dead deals.

A sole bidder can be a rational choice in a proprietary-sourced deal, but only if you have independent third-party valuation validation and are prepared to walk. In practice, sole-bidder processes without a credible walk-away option almost always clear at a discount to competitive process outcomes. GF Data’s Q1 2026 report shows a median 1.1 turn of EBITDA gap between sole-bidder and competitive-process deals in the LMM segment.

Sponsor thesis mismatch shows up in the first management meeting. If a firm’s platform investments across the last five years have no thematic overlap with your business, and if the partner cannot articulate specific value-creation levers in your sector within the first 30 minutes, the risk of them dropping in diligence is high. Look at each sponsor’s last 15 to 20 deals to assess pattern fit.

Exclusivity terms are frequently under-negotiated. A vague 90-day exclusivity without milestone gates gives the buyer optionality to slow-play diligence, discover a “problem,” and retrade at day 75. A well-negotiated exclusivity has diligence milestones at 30, 45, and 60 days, and springs back to the seller if the buyer misses them.

Retrade patterns are visible in the sponsor’s reputation. A private brief conversation with three or four sellers who have closed with the sponsor in the last 24 months will typically surface whether retrade behavior is systemic. Advisors with deep LMM relationships can and should conduct that back-channel diligence on behalf of the founder.

Finally, an advisor with a strong overall M&A brand but zero closed deals in your specific vertical in the last 24 months is a risk. Sector experience translates to buyer relationships, positioning fluency, and diligence anticipation. See our guides to M&A advisory and buy-side M&A advisory for advisor evaluation frameworks.

What are the 2024 to 2026 market dynamics affecting equity finance?

Three forces shape LMM equity finance in 2026: PE dry powder near a record $2.62 trillion globally per Bain & Company, senior debt costs still high at SOFR + 275 to 500 bps, and family-office direct-investment volume up more than 60% since 2021 per Campden Wealth. Together these forces produce structurally strong bid competition for well-prepared LMM assets, particularly in healthcare services, industrial services, and vertical SaaS.

According to Bain & Company’s Global Private Equity Report 2026, aggregate dry powder for buyouts closed 2025 at $2.62 trillion, of which roughly 22% is targeted at deals with enterprise values below $500M. That capital overhang creates persistent competitive tension for quality LMM assets and is a primary reason multiples for scaled healthcare, tech-enabled services, and vertical SaaS have remained resilient even in a higher-rate environment.

On the debt side, the SOFR curve as of Q2 2026 sits around 4.6%, meaning senior-secured LMM debt with a 275 to 450 bps spread clears at roughly 7.4% to 9.1% all-in per Federal Reserve H.15 data. That is meaningfully cheaper than 2023’s peaks, but still 300 to 400 bps above the pre-2022 baseline. The effect is that LMM buyers now run models with lower leverage assumptions and heavier equity checks, which pushes buyer economics toward higher-EBITDA-quality targets and away from thinly capitalized platforms.

Family-office direct investment has been the quiet story. Campden Wealth’s Global Family Office Report 2025 shows North American single-family offices allocating a median 28% of AUM to direct private equity, up from roughly 17% in 2021. For LMM sellers with a legacy or succession thesis, that translates into a materially deeper family-office buyer pool than existed even three years ago.

Sector-specific comps drive most decisions. According to GF Data’s Q1 2026 Report, LMM control deals closed at a median 7.3x TTM EBITDA. Vertical SaaS and specialty healthcare services routinely cleared above 10x. Traditional industrial and consumer platforms without differentiated growth stories cleared closer to 6.0x to 7.0x. High-quality outliers, particularly in home services and behavioral health, have crossed 12x in 2025 based on PwC’s US Deals 2026 Outlook.

How does CT Acquisitions help you find the right equity partner?

CT Acquisitions runs sell-side and capital-raise mandates specifically calibrated to the LMM segment. Our capital advisors identify the 40 to 80 sponsors and family offices most likely to value your specific business, build competitive tension across 3 to 6 finalists, and negotiate rollover, MIP, and governance terms to protect founder economics beyond the headline price.

The CT approach starts with a positioning workshop that identifies the two or three highest-value acquirer archetypes for your business, based on strategic fit, prior transaction history, and known appetite. We then build a targeted outreach list that avoids the shotgun approach many advisors default to, and we manage the process with founder-first process discipline: pre-launch quality of earnings, tight NDA and NPA hygiene, weekly buyer pipeline reviews, and disciplined LOI comparison beyond top-line price.

The differentiating outcomes we focus on include realized purchase price net of retrade, rollover value at second exit, working-capital and indebtedness adjustments at close, MIP participation and vesting, and post-close governance structure. Every one of those is a real dollar-value lever, and each is worth more attention than most LMM sellers give it in a first-time process.

For related capital-raise topics, see our guides to raise capital (the pillar hub), selling to a growth equity investor, lower-middle-market M&A advisor, family office vs PE buyer, and growth equity vs private equity.

How do you choose among competing advisors for an equity finance mandate?

Choose an advisor based on five criteria: closed transactions in your specific sector in the past 24 months, buyer coverage depth (relationships with the actual sponsors likely to bid), transparent fee structure, staffing model (partners execute vs handoff to associates), and reference calls with recent seller clients. Brand and league-table position matter less than sector-specific pattern recognition.

Ask for a list of the advisor’s closed transactions in the past 24 months, filtered to your sector and size range. Ask which sponsors and family offices they have direct partner-level relationships with. Ask who from the firm will actually staff your deal day to day, and how much of that time is partner time versus vice president or associate time. Ask for the names and phone numbers of three sellers they closed for in the last 12 months, and call all three. A serious advisor will provide all of that without hesitation.

Fee structures vary. Most LMM advisors use a modified Lehman formula plus a monthly retainer credited against success. A minority use a flat percentage. A small number use tiered fees with a lower baseline plus a meaningful success kicker above a value threshold. All can be reasonable. The key is transparency and alignment: the advisor should be economically incented to move the price up, not simply to close.

Sector experience shows up in first-meeting fluency. An advisor who has closed six healthcare services deals in the last 18 months can talk about Medicare reimbursement headwinds, credentialing risk, and payer concentration without prompting. An advisor with no sector experience will need to be educated on your business by you, which delays the process and increases the risk of buyer discovery driving retrade.

Cluster-related reading on our site: M&A advisory, buy-side M&A advisory, and lower-middle-market M&A advisor.

What does a 2024 to 2026 equity finance deal actually look like?

Recent named LMM equity finance transactions show consistent patterns: 7.0x to 10.5x multiples on healthcare services and vertical SaaS, 5.5x to 7.5x on traditional industrials, 20% to 35% founder rollover on control deals, and 45 to 65 day exclusivity periods. Below are five representative 2024 to 2026 comps drawn from public disclosures and sponsor investor pages.

Announced Company Sponsor / Investor Sector Structure Disclosed valuation clue
Feb 2024 KPS Global (freezer / cold-storage) Audax Private Equity acquires from CenterOak Industrial Control buyout Reported ~$500M EV, per Audax press release
Q1 2025 Beauty Industry Group Gauge Capital recapitalization Consumer / distribution Recap + growth Undisclosed EV, minority rollover retained by founders per Gauge Capital
Q3 2025 ITSelectSoft (vertical ERP) TA Associates recap Vertical SaaS Growth recap Undisclosed, TA’s stated LMM range is $40M to $500M equity, per TA Associates
2024 Weber-Stephen take-private BDT Capital Partners Consumer durables Take-private + rollover ~$3.7B EV at premium to VWAP, per SEC filings
2025 Southern Rebar and Supplies Trive Capital recap Industrial distribution Control + rollover Undisclosed EV, Trive’s LMM range is $30M to $200M equity per Trive Capital

The pattern to notice: sponsors are willing to write meaningful equity checks in the LMM segment, and rollover is now expected rather than a negotiating give. In every one of the above five deals, the founder or continuing management retained meaningful ownership post-close. Ten years ago, cash-out full sales were more common. Today, if a sponsor is not asking for rollover, it is often a signal that the sponsor does not believe in the second-bite upside enough to want the operator invested in it.

A second pattern is that valuation is not a single number. It is a bundle: the base multiple, the working capital target, the indebtedness definition, the escrow, the R&W retention, and the earnout. Two LOIs at the “same” 8.0x can have $2M to $5M of real economic difference once the bundle is fully priced. This is where advisor discipline matters most.

What are the alternatives if equity finance is not the right fit?

If equity finance is not the right fit, the credible alternatives for an LMM operator are senior debt (bank or unitranche), mezzanine debt, an ESOP transition, a management buyout (MBO), a full third-party sale without founder rollover, or simply staying private and self-funding growth. Each has a specific fit profile, cost, and control implication.

An ESOP transition is often the right answer for founders with strong operating teams, a preference for legacy continuity, and moderate liquidity needs. ESOPs offer significant tax advantages under Section 1042 and can be structured to give the founder immediate partial liquidity while transitioning ownership over 10 to 20 years. They work best for businesses with stable cash flow and low customer concentration.

A management buyout (MBO) can work when the existing management team is capable of running the business without the founder and has access to seller-note financing plus mezzanine or growth equity from a co-investor. MBO valuations typically clear 0.5 to 1.5 turns of EBITDA below a competitive process because there is no external bid tension, but they preserve legacy and reward the team that built the business.

Debt-only paths (senior + mezzanine) can fund a lot of growth without dilution when the business has predictable cash flow. See business acquisition loans and mezzanine debt for acquisitions for the size-appropriate framing.

Staying private is a legitimate answer. Many LMM operators find that the intangible costs of institutional capital (board obligations, quarterly reporting cadence, reduced strategic flexibility) outweigh the financial benefits, particularly if the business is generating adequate cash flow to fund organic growth. The right answer depends on the founder’s personal financial goals, family situation, and appetite for institutional partnership.

Frequently asked questions

Is equity finance the same as venture capital?

No. Equity finance is the broader category of raising capital by selling ownership. Venture capital is one subtype, aimed at high-growth, pre-profit companies. For an LMM operator with $1M to $25M of EBITDA, the relevant equity finance sources are growth equity funds, control PE sponsors, and family offices, not VC firms.

How much of my company will I give up in an equity finance round?

For a growth equity minority round, expect to sell 15% to 40% of the company. For a control recapitalization or majority sale, sponsors typically buy 60% to 90% and ask you to roll 10% to 40% of your proceeds back into the new deal. Structure varies by check size, EBITDA, and your desired post-close role.

How long does an equity finance process take for a lower-middle-market business?

A well-run competitive process usually takes 5 to 9 months from advisor mandate to wire. Preparation and materials take 6 to 10 weeks. Buyer outreach and management meetings run 8 to 12 weeks. Diligence, quality of earnings, and legal close typically consume the final 60 days.

What multiple should I expect for an equity finance transaction in 2026?

GF Data’s Q1 2026 report shows LMM control transactions clearing at a median 7.3x TTM EBITDA, with a range of roughly 5.5x for sub-$3M EBITDA industrials to 10.5x plus for scaled healthcare services and vertical SaaS. Multiples move with sector, growth, customer concentration, and process competitiveness.

Can I keep control of my business and still raise equity finance?

Yes, if you go the minority-growth-equity route. Sponsors such as Summit Partners, TA Associates, and Serent Capital write minority checks and take board seats but leave founders in operational control. Governance protections such as consent rights on major spending, hiring, and debt are standard, but day-to-day authority stays with management.

Do I need an investment banker or M&A advisor to raise equity finance?

For any raise above roughly $5M of equity check size, yes. A study by Axial in 2024 found that LMM sellers using an M&A advisor cleared prices 15% to 25% higher on average than unrepresented sellers. Below that threshold, a placement agent or a direct search may work if the founder has an existing sponsor network.

What is a second bite of the apple in an equity finance deal?

Second bite refers to the future exit value of rollover equity a founder keeps in the recapitalized company. A founder who rolls 30% of $30M in proceeds, or $9M, and exits three to five years later at a 2x MOIC on the rollover, captures another $18M pretax at second exit, on top of the first close proceeds.

How do family offices differ from private equity funds in an equity finance context?

Family offices such as Pritzker Private Capital and BDT & MSD Partners typically deploy long-dated or evergreen capital, accept lower leverage, and hold assets 7 to 15 years, versus PE’s typical 3 to 6 year hold. They tend to value founder legacy, are often willing to take minority stakes, and can be a better fit for owners who want a slower exit path.

Find the right equity partner for your business

CT Acquisitions matches LMM operators with the family offices, growth-equity funds, and structured-capital investors that fit your revenue profile, growth thesis, and post-close role preferences. Talk to a CT capital advisor about your options.

Talk to a CT capital advisor

Related reading from CT Acquisitions